BBC Sport

Daily pill daraxonrasib doubles survival time for pancreatic cancer patients (opens in new tab)

Covered by 3 sources See all sources covering this story including kite.kagi.com, mediafax.roDiscussed on Hacker News

The drug, daraxonrasib, has been hailed as a breakthrough in managing the deadliest of all the major cancers.

Read the original article
Sign in to keep reading the full article.
Sign UpLog In

Covered in 3 articles

kite.kagi.com·

Daraxonrasib doubles survival in pancreatic cancer trial

Feeds

In other languages

mediafax.ro·

O pastilă zilnică dublează perioada de supraviețuire pentru pacienții diagnosticați cu cel mai agresiv tip de cancer

Feeds
digi24.ro·

O pastilă zilnică dublează durata de supraviețuire a pacienților cu cancer pancreatic

Feeds

Keyboard Shortcuts

Navigation

Next / previous post
j/k
Open post
oorEnter
Preview post
v

Post Actions

Love post
a
Like post
l
Dislike post
d
Undo reaction
u
Save / unsave
s

Recommendations

Add interest / feed
Enter
Not interested
x

Go to

Home
gh
Interests
gi
Feeds
gf
Likes
gl
History
gy
Changelog
gc
Settings
gs
Discover
gb
Search
/

General

Show this help
?
Submit feedback
!
Close modal / unfocus
Esc

Press ? anytime to show this help